Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Italy to resume use of AstraZeneca jab from Friday - PM Draghi

Thu, 18th Mar 2021 17:16

ROME, March 18 (Reuters) - Italy will resume using the
AstraZeneca COVID-19 vaccine from Friday, Prime Minister Mario
Draghi said, following a report by the European Medicines Agency
which judged that its benefits outweighed risks.

Italy was among a dozen countries that had suspended the use
of the vaccine earlier this week after reports of rare blood
disorders in a handful of people who had recently received a
jab.

"The government's priority remains to vaccinate as many
people as possible as quickly as possible," Draghi said in a
brief statement.
(Reporting By Gavin Jones, editing by Crispian Balmer)

Related Shares

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.